bioAffinity technologies is experiencing growth, with its CyPath Lung sales increasing and the company projecting strong growth amid market fluctuations. The company has also raised funds through a public offering, selling shares and generating revenue. The outlook for bioAffinity technologies appears positive, with some reports indicating a surge in its stock and the company eyeing further expansion amid growing market demand.